These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 22055344)

  • 1. Autophagy proteins regulate the secretory component of osteoclastic bone resorption.
    DeSelm CJ; Miller BC; Zou W; Beatty WL; van Meel E; Takahata Y; Klumperman J; Tooze SA; Teitelbaum SL; Virgin HW
    Dev Cell; 2011 Nov; 21(5):966-74. PubMed ID: 22055344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.
    Na W; Lee EJ; Kang MK; Kim YH; Kim DY; Oh H; Kim SI; Oh SY; Kang YH
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K.
    Ohmae S; Noma N; Toyomoto M; Shinohara M; Takeiri M; Fuji H; Takemoto K; Iwaisako K; Fujita T; Takeda N; Kawatani M; Aoyama M; Hagiwara M; Ishihama Y; Asagiri M
    Sci Rep; 2017 Mar; 7():41710. PubMed ID: 28300073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab GTPases in Osteoclastic Bone Resorption and Autophagy.
    Roy M; Roux S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption.
    Ng PY; Cheng TS; Zhao H; Ye S; Sm Ang E; Khor EC; Feng HT; Xu J; Zheng MH; Pavlos NJ
    J Bone Miner Res; 2013 Jan; 28(1):119-34. PubMed ID: 22887640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the ATG4-LC3 pathway suppressed osteoclast maturation.
    Hiura F; Kawabata Y; Aoki T; Mizokami A; Jimi E
    Biochem Biophys Res Commun; 2022 Dec; 632():40-47. PubMed ID: 36198202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugar transporter Slc37a2 regulates bone metabolism in mice via a tubular lysosomal network in osteoclasts.
    Ng PY; Ribet ABP; Guo Q; Mullin BH; Tan JWY; Landao-Bassonga E; Stephens S; Chen K; Yuan J; Abudulai L; Bollen M; Nguyen ETTT; Kular J; Papadimitriou JM; Søe K; Teasdale RD; Xu J; Parton RG; Takayanagi H; Pavlos NJ
    Nat Commun; 2023 Feb; 14(1):906. PubMed ID: 36810735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.
    Yang DQ; Feng S; Chen W; Zhao H; Paulson C; Li YP
    J Bone Miner Res; 2012 Aug; 27(8):1695-707. PubMed ID: 22467241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUFY4 deletion prevents pathological bone loss by blocking endo-lysosomal trafficking of osteoclasts.
    Kim M; Park JH; Go M; Lee N; Seo J; Lee H; Kim D; Ha H; Kim T; Jeong MS; Kim S; Kim T; Kim HS; Kang D; Shim H; Lee SY
    Bone Res; 2024 May; 12(1):29. PubMed ID: 38744829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The osteoclast and its unique cytoskeleton.
    Teitelbaum SL
    Ann N Y Acad Sci; 2011 Dec; 1240():14-7. PubMed ID: 22172034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased synthesis and specific localization of a major lysosomal membrane sialoglycoprotein (LGP107) at the ruffled border membrane of active osteoclasts.
    Akamine A; Tsukuba T; Kimura R; Maeda K; Tanaka Y; Kato K; Yamamoto K
    Histochemistry; 1993 Aug; 100(2):101-8. PubMed ID: 8244761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The resorptive apparatus of osteoclasts supports lysosomotropism and increases potency of basic versus non-basic inhibitors of cathepsin K.
    Fuller K; Lindstrom E; Edlund M; Henderson I; Grabowska U; Szewczyk KA; Moss R; Samuelsson B; Chambers TJ
    Bone; 2010 May; 46(5):1400-7. PubMed ID: 20097319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A difference in the enzyme contents of resorption lacunae and secondary lysosomes of osteoclasts.
    Karhukorpi EK; Vihko P; Väänänen K
    Acta Histochem; 1992; 92(1):1-11. PubMed ID: 1580139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts.
    Cremasco V; Decker CE; Stumpo D; Blackshear PJ; Nakayama KI; Nakayama K; Lupu TS; Graham DB; Novack DV; Faccio R
    J Bone Miner Res; 2012 Dec; 27(12):2452-63. PubMed ID: 22806935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion.
    Dawodu D; Patecki M; Hegermann J; Dumler I; Haller H; Kiyan Y
    Sci Rep; 2018 Aug; 8(1):11604. PubMed ID: 30072716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hem1 is essential for ruffled border formation in osteoclasts and efficient bone resorption.
    Werbenko E; de Gorter DJJ; Kleimann S; Beckmann D; Waltereit-Kracke V; Reinhardt J; Geers F; Paruzel P; Hansen U; Pap T; Stradal TEB; Dankbar B
    Sci Rep; 2024 Apr; 14(1):8109. PubMed ID: 38582757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V-ATPase a3 Subunit in Secretory Lysosome Trafficking in Osteoclasts.
    Nakanishi-Matsui M; Matsumoto N
    Biol Pharm Bull; 2022; 45(10):1426-1431. PubMed ID: 36184499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological sequestration of intracellular cholesterol in late endosomes disrupts ruffled border formation in osteoclasts.
    Zhao H; Väänänen HK
    J Bone Miner Res; 2006 Mar; 21(3):456-65. PubMed ID: 16491294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border.
    Baron R; Neff L; Louvard D; Courtoy PJ
    J Cell Biol; 1985 Dec; 101(6):2210-22. PubMed ID: 3905822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice.
    Daroszewska A; van 't Hof RJ; Rojas JA; Layfield R; Landao-Basonga E; Rose L; Rose K; Ralston SH
    Hum Mol Genet; 2011 Jul; 20(14):2734-44. PubMed ID: 21515589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.